Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?
Increased expression of the enzyme autotaxin (ATX) and the consequently increased levels of its product, lysophosphatidic acid (LPA), have been reported in several primary tumors. The role of LPA as a direct modulator of tumor cell functions—motility, invasion and migration capabilities as well as r...
Main Authors: | Sistiana Aiello, Federica Casiraghi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/6/1390 |
Similar Items
-
Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
by: Eunah Shin, et al.
Published: (2019-08-01) -
Autotaxin, lysophosphatidate and taxol resistance
by: Samadi, Nasser
Published: (2009) -
Regulation of Tumor Immunity by Lysophosphatidic Acid
by: Sue Chin Lee, et al.
Published: (2020-05-01) -
Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
by: Sindhu Ramesh, et al.
Published: (2018-06-01) -
Autotaxin promotes cancer cell invasion via the lysophosphatidic acid receptor 4
by: Harper, Kelly
Published: (2010)